Search Results - "Gockman, Kelsey"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients by Zuo, Yu, Warnock, Mark, Harbaugh, Alyssa, Yalavarthi, Srilakshmi, Gockman, Kelsey, Zuo, Melanie, Madison, Jacqueline A., Knight, Jason S., Kanthi, Yogendra, Lawrence, Daniel A.

    Published in Scientific reports (15-01-2021)
    “…Patients with coronavirus disease-19 (COVID-19) are at high risk for thrombotic arterial and venous occlusions. However, bleeding complications have also been…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Neutrophil extracellular traps and thrombosis in COVID-19 by Zuo, Yu, Zuo, Melanie, Yalavarthi, Srilakshmi, Gockman, Kelsey, Madison, Jacqueline A., Shi, Hui, Woodard, Wrenn, Lezak, Sean P., Lugogo, Njira L., Knight, Jason S., Kanthi, Yogendra

    Published in Journal of thrombosis and thrombolysis (01-02-2021)
    “…Studies of patients with COVID-19 have demonstrated markedly dysregulated coagulation and a high risk of morbid arterial and venous thrombotic events. Elevated…”
    Get full text
    Journal Article
  4. 4

    Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19 by Shi, Hui, Zuo, Yu, Yalavarthi, Srilakshmi, Gockman, Kelsey, Zuo, Melanie, Madison, Jacqueline A., Blair, Christopher, Woodward, Wrenn, Lezak, Sean P., Lugogo, Njira L., Woods, Robert J., Lood, Christian, Knight, Jason S., Kanthi, Yogendra

    Published in Journal of leukocyte biology (01-01-2021)
    “…Severe cases of coronavirus disease 2019 (COVID‐19) are regularly complicated by respiratory failure. Although it has been suggested that elevated levels of…”
    Get full text
    Journal Article
  5. 5

    Endothelial Cell–Activating Antibodies in COVID‐19 by Shi, Hui, Zuo, Yu, Navaz, Sherwin, Harbaugh, Alyssa, Hoy, Claire K., Gandhi, Alex A., Sule, Gautam, Yalavarthi, Srilakshmi, Gockman, Kelsey, Madison, Jacqueline A., Wang, Jintao, Zuo, Melanie, Shi, Yue, Maile, Michael D., Knight, Jason S., Kanthi, Yogendra

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-07-2022)
    “…Objective While endothelial dysfunction has been implicated in the widespread thromboinflammatory complications of COVID‐19, the upstream mediators of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by β2 Integrin Mac‐1 by Sule, Gautam, Kelley, William J., Gockman, Kelsey, Yalavarthi, Srilakshmi, Vreede, Andrew P., Banka, Alison L., Bockenstedt, Paula L., Eniola‐Adefeso, Omolola, Knight, Jason S.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2020)
    “…Objective While the role of antiphospholipid antibodies in activating endothelial cells has been extensively studied, the impact of these antibodies on the…”
    Get full text
    Journal Article
  8. 8

    Autoantibodies stabilize neutrophil extracellular traps in COVID-19 by Zuo, Yu, Yalavarthi, Srilakshmi, Navaz, Sherwin A, Hoy, Claire K, Harbaugh, Alyssa, Gockman, Kelsey, Zuo, Melanie, Madison, Jacqueline A, Shi, Hui, Kanthi, Yogendra, Knight, Jason S

    Published in JCI insight (09-08-2021)
    “…The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils is recognized to play an important role in the thromboinflammatory milieu…”
    Get full text
    Journal Article
  9. 9

    Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series by Madison, Jacqueline A, Gockman, Kelsey, Hoy, Claire, Tambralli, Ajay, Zuo, Yu, Knight, Jason S

    Published in Pediatric rheumatology online journal (23-02-2022)
    “…Pediatric antiphospholipid syndrome (APS) is a thromboinflammatory disease characterized by the presence of circulating antiphospholipid antibodies and either…”
    Get full text
    Journal Article
  10. 10

    Antineutrophil properties of natural gingerols in models of lupus by Ali, Ramadan A, Gandhi, Alex A, Dai, Lipeng, Weiner, Julia, Estes, Shanea K, Yalavarthi, Srilakshmi, Gockman, Kelsey, Sun, Duxin, Knight, Jason S

    Published in JCI insight (08-02-2021)
    “…Ginger is known to have antiinflammatory and antioxidative effects and has traditionally been used as an herbal supplement in the treatment of various chronic…”
    Get full text
    Journal Article
  11. 11

    Predictors and Interrelationship of Patient‐Reported Outcomes in Antiphospholipid Syndrome: A Cross‐Sectional Study by Weiner, Julia K., Smith, Tristin, Hoy, Claire K., Sarosh, Cyrus, Madison, Jacqueline A., Ambati, Amala, Tambralli, Ajay, Peters, Noah, Packel, Corinne, Gockman, Kelsey, Zuo, Yu, Briceño, Emily M., Nagaraja, Vivek, Knight, Jason S.

    Published in ACR open rheumatology (01-01-2023)
    “…Objective This study assessed patient‐reported outcomes (PROs) in individuals with persistently positive antiphospholipid antibodies (aPL) to better understand…”
    Get full text
    Journal Article
  12. 12

    NETs in APS: Current Knowledge and Future Perspectives by Tambralli, Ajay, Gockman, Kelsey, Knight, Jason S.

    Published in Current rheumatology reports (26-08-2020)
    “…Purpose of Review Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease that is primarily treated with anticoagulation. Better understanding the…”
    Get full text
    Journal Article
  13. 13

    Neutrophil extracellular traps in COVID-19 by Zuo, Yu, Yalavarthi, Srilakshmi, Shi, Hui, Gockman, Kelsey, Zuo, Melanie, Madison, Jacqueline A, Blair, Christopher, Weber, Andrew, Barnes, Betsy J, Egeblad, Mikala, Woods, Robert J, Kanthi, Yogendra, Knight, Jason S

    Published in JCI insight (04-06-2020)
    “…In severe cases of coronavirus disease 2019 (COVID-19), viral pneumonia progresses to respiratory failure. Neutrophil extracellular traps (NETs) are…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16